New Carcinogen Found in Already-Contaminated Drugs Valsartan and Losartan
Popular blood pressure drugs have faced multiple recalls over the past few years relating to a carcinogen, N-Nitrosodimethylamine (NDMA), found in the drugs. Valsartan and losartan are two big examples, with millions of patients taking these blood pressure drugs worldwide. Just as manufacturers are dealing with the aftermath of massive recalls, manufacturers for valsartan, losartan, and irbesartan are facing more recalls over a second carcinogen found in the drugs.
As reported by Bloomberg News, “azido impurities” have been found in some lots of certain blood pressure drugs. Azido impurities are carcinogenic, like NDMA, in that they can change a person’s DNA and increase the risk that a person will develop cancer. The contaminated drugs at issue were recalled in Canada and Europe but have not yet been recalled in the United States.
Drug recalls are issued when drugs are found to be defective and potentially dangerous. Zantac was pulled from the market for being contaminated with high levels of NDMA that increase the longer the drug sits on the shelf. Many Zantac cancer claims lawyers are also representing plaintiffs injured by recalled blood pressure drugs.
Valsartan and Losartan Cancer Claims
Mass tort lawyers are helping hundreds of plaintiffs seek compensation from the manufacturers of Valsartan, Losartan, and Irbesartan for selling prescription drugs that contain a cancer-causing compound. Lawsuits concerning contaminated blood pressure drugs are centralized in multidistrict litigation (MDL), which is being overseen by the United States District Court for the District of New Jersey.
Plaintiffs who have filed lawsuits against the manufacturers of recalled blood pressure medications have been diagnosed with different types of cancer, some of which include, but may not be limited to, the following:
- Stomach cancer
- Liver cancer
- Bladder cancer
- Pancreatic cancer
- Colon cancer
- Kidney cancer
- Non-Hodgkin’s Lymphoma (NHL)
- Colorectal cancer
Because many factors can contribute to the development of cancer, dangerous drug lawyers are careful to gather the necessary information that can support a link between the use of contaminated blood pressure drugs and a diagnosis of cancer.
Pharmaceutical companies have a duty to ensure the drugs they design, manufacture, distribute, and sell to patients are safe. A manufacturer’s failure to timely identify the presence of a carcinogen in a popular blood pressure drug is conduct that warrants legal action.
Contact Searcy Denney Today for a Free Consultation
If you or a loved one has been diagnosed with cancer after long-term use of blood pressure drugs, such as valsartan or losartan, you may have a potential legal claim. By speaking with a defective drug lawyer, you may find out whether you have grounds to file a lawsuit.
The Valsartan cancer claims lawyers of Searcy Denney have a wealth of experience when it comes to mass tort litigations involving defective and dangerous drugs. To receive your free case evaluation, contact our office today by calling (800) 780-8607 or by completing a free case evaluation form on our website.